[DOI] [PubMed] [Google Scholar] 125.Saxena A.R., Banerjee A., Corbin K.D., Parsons S.A., Smith S.R
3000
doi: 10.3389/fcell.2025.1596421 Received 19 March 2025 Accepted 22 April 2025 Published 13 May 2025 Volume 13 - 2025 Edited by Matteo Avella, Sidra Medicine, Qatar Reviewed by Jurandy Penitente-Filho, JPF Consultoria, Brazil Qi Yin, Carnegie Institution for Science, United States Updates Copyright 2025 Gmez-Elas, Luque, Oscoz-Susino, Novero, Briski, Ksparas, Steeman, Stival, Lavolpe, Julianelli, Geller, Attie, Vassena, Krapf and Buffone
This compound is not approved as a drug, diagnostic agent, or dietary ingredient, and is not manufactured, packaged, or marketed for human consumption, self-experimentation, clinical application, or any use outside properly designed and ethically approved research protocols.
If 10 mg produces excellent efficacy but borderline intolerable nausea, try 7.5 mg for 6 to 8 weeks to assess whether efficacy remains adequate with improved tolerability
